[ad_1]
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Organogenesis Holdings Inc. (“Organogenesis”) ((ORGO). The action charges Organogenesis with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects. As a result of Organogenesis’s materially misleading statements to the public, Organogenesis’s investors have suffered significant losses.
TO VIEW OUR VIDEO, PLEASE CLICK HERE
CLICK HERE TO SUBMIT YOUR ORGANOGENESIS LOSSES. YOU CAN ALSO CLICK ON THE FOLLOWING LINK OR COPY AND PASTE IN YOUR BROWSER: https://www.ktmc.com/organogenesis-class-action-lawsuit?utm_source=PR&utm_medium=link&utm_campaign=organogenesis
LEAD PLAINTIFF DEADLINE: February 8, 2022
CLASS PERIOD: March 17, 2021 through October 11, 2021
CONTACT AN ATTORNEY TO DISCUSS YOUR RIGHTS:
James Maro, Esq. (484) 270-1453 or Toll Free (844) 887-9500 or Email at info@ktmc.com
ORGANOGENESIS’S ALLEGED MISCONDUCT
Organogenesis is a regenerative medicine company that develops, manufactures, and commercializes solutions for advanced wound care, surgical and sports medicine markets. The company’s advanced wound care products include “Affinity,” an amniotic allograft wound covering and surgical …
Full story available on Benzinga.com
[ad_2]
Source link
